Immunophenotyping of peripheral eosinophils demonstrates activation in eosinophilic esophagitis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 53, Issue 1, 2011, Pages 40-47

  Nguyen, Tammie ^a   Gernez, Yael ^a   Fuentebella, Judy ^a   Patel, Anup ^a   Tirouvanziam, Rabindra ^a   Reshamwala, Neha ^a   Bass, Dorsey ^a   Berquist, William E ^a   Cox, Kenneth L ^a   Kerner, John A ^a   Nadeau, Kari C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

activation; atopy; phosphoepitope; signal transducer and activator of transcription

Indexed keywords

STAT1 PROTEIN; STAT6 PROTEIN; TRANSCRIPTION FACTOR;

ADOLESCENT; ADULT; ARTICLE; CD3+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; EOSINOPHILIC ESOPHAGITIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; INFANT; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; ANTIGENS, CD; ANTIGENS, CD3; CELL ADHESION MOLECULES; CHILD; CHILD, PRESCHOOL; EOSINOPHILIC ESOPHAGITIS; EOSINOPHILS; FEMALE; GPI-LINKED PROTEINS; HUMANS; IMMUNOPHENOTYPING; IMMUNOSUPPRESSION; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SEVERITY OF ILLNESS INDEX; STAT1 TRANSCRIPTION FACTOR; STAT6 TRANSCRIPTION FACTOR; YOUNG ADULT;

EID: 79959817766     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e318212647a     Document Type: Article

References (35)

1. Gupte AR, Draganov PV. Eosinophilic esophagitis. World J Gastroenterol 2009;15:17-24.
2. Mishra A. Mechanism of eosinophilic esophagitis. Immunol Allergy Clin North Am 2009;29:29-40.
3. Shah A, Kagalwalla AF, Gonsalves N, et al. Histopathologic variability in children with eosinophilic esophagitis. Am J Gastroenterol 2009; 104:716-21.
4. Aceves SS, Bastian JF, Newbury RO, et al. Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children. Am J Gastroenterol 2007;102:2271-80.
5. Stein ML, Collins MH, Villanueva JM, et al. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol 2006; 118:1312-9. (Pubitemid 44872890)
6. Kapel RC, Miller JK, Torres C, et al. Eosinophilic esophagitis: a prevalent disease in the United States that affects all age groups. Gastroenterology 2008;134:1316-21. (Pubitemid 351615360)
7. Lucendo AJ, Lucendo B. An update on the immunopathogenesis of eosinophilic esophagitis. Expert Rev Gastroenterol Hepatol 4: 141-8.
8. Gupta SK. Noninvasive markers of eosinophilic esophagitis. Gastrointest Endosc Clin N Am 2008;18:157-67. (Pubitemid 350166937)
9. Neilsen CV, Bryce PJ. Interleukin-13 directly promotes oesophagus production of CCL11 and CCL24 and the migration of eosinophils. Clin Exp Allergy 40:427-34.
10. Kroegel C, Liu MC, Hubbard WC, et al. Blood and bronchoalveolar eosinophils in allergic subjects after segmental antigen challenge: surface phenotype, density heterogeneity, and prostanoid production. J Allergy Clin Immunol 1994;93:725-34. (Pubitemid 24132428)
11. Mengelers HJ, Maikoe T, Brinkman L, et al. Immunophenotyping of eosinophils recovered from blood and BAL of allergic asthmatics. Am J Respir Crit Care Med 1994;149(2 Pt 1):345-51. (Pubitemid 24068978)
12. Yoon J, Terada A, Kita H. CD66b regulates adhesion and activation of human eosinophils. J Immunol 2007;179:8454-62.
13. Stocks SC, Ruchaud-Sparagano MH, Kerr MA, et al. CD66: role in the regulation of neutrophil effector function. Eur J Immunol 1996;26: 2924-2932. (Pubitemid 26411496)
14. Gernez Y, Tirouvanziam R, Nguyen KD, et al. Altered phosphorylated signal transducer and activator of transcription profile of CD4CD161 T cells in asthma: modulation by allergic status and oral corticosteroids. J Allergy Clin Immunol 2007;120: 1441-8. (Pubitemid 350216597)
15. Brierley MM, Fish EN. Stats: multifaceted regulators of transcription. J Interferon Cytokine Res 2005;25:733-44. (Pubitemid 43071210)
16. Pazdrak K, Stafford S, Alam R. The activation of the Jak-STAT 1 signaling pathway by IL-5 in eosinophils. J Immunol 1995;155:397-402.
17. van der Bruggen T, Caldenhoven E, Kanters D, et al. Interleukin-5 signaling in human eosinophils involves JAK2 tyrosine kinase and Stat1 alpha. Blood 1995;85:1442-8.
18. Takatsu K, Nakajima H. IL-5 and eosinophilia. Curr Opin Immunol 2008;20:288-94.
19. Mikhak Z, Fleming CM, Medoff BD, et al. STAT1 in peripheral tissue differentially regulates homing of antigen-specific Th1 and Th2 cells. J Immunol 2006;176:4959-67.
20. Mishra A, Hogan SP, Brandt EB, et al. IL-5 promotes eosinophil trafficking to the esophagus. J Immunol 2002;168:2464-9. (Pubitemid 34171851)
21. Kuperman DA, Schleimer RP. Interleukin-4, interleukin-13, signal transducer and activator of transcription factor 6, and allergic asthma. Curr Mol Med 2008;8:384-92.
22. Takeda K, Kishimoto T, Akira S. STAT6: its role in interleukin 4-mediated biological functions. J Mol Med 1997;75:317-26. (Pubitemid 27247963)
23. Atkins D, Kramer R, Capocelli K, et al. Eosinophilic esophagitis: the newest esophageal inflammatory disease. Nat Rev Gastroenterol Hepatol 2009;6:267-78.
24. Odaka M, Matsukura S, Kuga H, et al. Differential regulation of chemokine expression by Th1 and Th2 cytokines and mechanisms of eotaxin/CCL-11 expression in human airway smooth muscle cells. Int Arch Allergy Immunol 2007;143(Suppl 1):84-8. (Pubitemid 46854799)
25. Hoeck J, Woisetschlager M. Activation of eotaxin-3/CCLl26 gene expression in human dermal fibroblasts is mediated by STAT6. J Immunol 2001;167:3216-22. (Pubitemid 32852561)
26. Matsukura S, Stellato C, Plitt JR, et al. Activation of eotaxin gene transcription by NF-kappa B and STAT6 in human airway epithelial cells. J Immunol 1999;163:6876-83.
27. Kim Y, Munoz A, Hwang P, Nadeau KC. Migration of regulatory T cells toward airway epithelial cells is impaired in chronic rhinosinusitis. Clin Immunol 2010;137:111-21.
28. Fuentebella J, Patel A, Nguyen T, et al. Increased number of regulatory T cells in children with eosinophilic esophagitis. J Pediatr Gastroenterol 2010;51:283-9.
29. Tirouvanziam R, Gernez Y, Conrad CK, et al. Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways. Proc Natl Acad Sci U S A 2008;105:4335-9. (Pubitemid 351754381)
30. Kabesch M, Schedel M, Carr D, et al. IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma. J Allergy Clin Immunol 2006;117:269-74. (Pubitemid 43190139)
31. Rothenberg ME, Spergel JM, Sherrill J, et al. Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nat Genet 2010;42: 289-291.
32. Ferre-Ybarz L, Nevot Falco S, Plaza-Martin AM. Eosinophilic oesophagitis: clinical manifestations and treatment options. The role of the allergologist. Allergol Immunopathol (Madr) 2008;36:358-65.
33. Lucendo AJ, De Rezende L, Comas C, et al. Treatment with topical steroids downregulates IL-5, eotaxin-1/CCL11, and eotaxin-3/CCL26 gene expression in eosinophilic esophagitis. Am J Gastroenterol 2008; 103:2184-93.
34. Straumann A, Bauer M, Fischer B, et al. Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response. J Allergy Clin Immunol 2001;108:954-61. (Pubitemid 33151548)
35. Zhang SY, Boisson-Dupuis S, Chapgier A, et al. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense. Immunol Rev 2008;226:29-40.